-
August 26, 2022 Lupin Announces UK MHRA Approval of Lutio® (Tiotropium bromide inhalation powder) for Treatment of COPD
-
August 25, 2022 Lupin and I’rom Enter into an Exclusive Licensing Agreement for Denosumab biosimilar for Japan
-
August 24, 2022 Lupin Receives Approval from U.S. FDA for Formoterol Fumarate Inhalation Solution
-
August 18, 2022 Lupin Receives Approval from U.S. FDA for Rufinamide Tablets USP
-
August 12, 2022 Lupin Receives Approval from U.S. FDA for Meclizine Hydrochloride Tablets USP
-
August 3, 2022 Lupin Q1 FY2023 Results
-
July 25, 2022 Lupin Receives Approval from U.S. FDA for Azilsartan Medoxomil Tablets
-
July 19, 2022 Lupin Diagnostics Launches its First Reference Laboratory in Ranchi
-
July 13, 2022 Lupin Foundation is Transforming Communities and Lives in Bharatpur and Alwar
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications